Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
BMS, Ono sue Amgen over proposed Opdivo biosimilar
BMS and Ono are suing Amgen in Delaware over claims that its proposed biosimilar would tread on a number of patents for Opdivo.
Fraiser Kansteiner
Sep 16, 2026 11:08am
Mucinex maker invests $600 million in US operations overhaul
Sep 16, 2026 10:30am
Why Earlier Commercial Involvement Drives Smarter Strategy
Brought to you by
Acumetis
Legend Biotech names Novartis veteran Ingrid Zhang as new CEO
Sep 16, 2026 10:12am
Advancing mCSPC Treatment: A Closer Look at ADT + Darolutamide with Dr. Rana McKay
Brought to you by
Bayer
Ori secures $120M commercial cell therapy manufacturing accord
Sep 16, 2026 9:02am
